Absence of chronic hepatitis E in a German cohort of common variable immunodeficiency patients

Infectious Disease Reports

Volumn 4, Issue 2, 2012, Pages 114-115

  Pischke, Sven ^a   Horn Wichmann, Ruediger ^a   Ernst, Diana ^a   Georg Meyer, Bjoern ^a   Raupach, Regina ^a   Ahrenstorf, Gerrit ^a   Schmidt, Reinhold Ernst ^b   Manns, Michael Peter ^a   Witte, Torsten ^a   Wedemeyer, Heiner ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Common variable immunodeficiency; Hepatitis E

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HEPATITIS E; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PERSISTENT INFECTION;

EID: 84866790290     PISSN: None     EISSN: 20367449     Source Type: Journal    
DOI: 10.4081/idr.2012.e28     Document Type: Article

References (10)

1. Pischke S, Heim A, Bremer B, et al. Hepatitis E: an emerging infectious disease in Germany? Z Gastroenterol 2011;49: 1255-7.
2. Pischke S, Wedemeyer H. Chronic hepatitis E in liver transplant recipients: a significant clinical problem? Minerva Gastroenterol Dietol 2010;56:121-8.
3. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterol 2012;in print.
4. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008;358:811-7.
5. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010;153:85-9.
6. Park MA, Li JT, Hagan JB, et al. Common variable immunodeficiency: a new look at an old disease. Lancet 2008;372:489-502.
7. Maarschalk-Ellerbroek LJ, Hoepelman IM, Ellerbroek PM. Immunoglobulin treatment in primary antibody deficiency. Int J Antimicrob Agents 2011;37:396-404.
8. Pischke S, Suneetha PV, Baechlein C, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010;16:74-82.
9. Suneetha PV, Pischke S, Schlaphoff V, et al. HEV-specific T-cell responses are associated with control of HEV infection. Hepatology 2012;55:695-708.
10. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010;376:895-902.